If by assets you mean cars and hookers and cars for hookers, then I’d agree with your assessment.

Good call Mikey! He likes it Mikey likes it!

Nice week AMRX ??

Multiple promoters here. Not just the one. Prove me wrong, I could care less.

Literally has nothing to do with what I’ve said and certainly is a prediction I would only make with another reverse split... which would make the 5th reverse split in less than 5 years. Best wishes with your investment and/or day job.

Good one, guy! ?? ??

More paid promoters than rioters 2020 https://stocktrades.exchange/2020/01/07/iwytsomfgtvvwartiwyhok-3/

4 reverse splits since 2017

Also smells like paid promoters being sure to get the last word on how great this stock is. Only roses touch the toilet here.

Shorts and scares. Plus the whole generic pharmaceutical market has been in the crapper for years. Amneal has done great things during that time like launching high value generics and acquiring valuable manufacturers and distributors. It’s only a matter of time before their NDAs and bioequivalents start being major profit centers. Glad you’re on board with this little pharmaceutical company that could (and has!)

https://www.fda.gov/industry/fda-user-fee-programs/generic-drug-user-fee-amendments

Wall Street wasn’t a movie about pharmaceutical manufacturing in America because it is boring and expensive. Good luck making money on your overpriced shares that you simply could not buy at the bid.

I’d be happy to pay if you’re right lol

Minus 10% drops + 3% gains. Closing at 1.08

After all this time, what’s the harm in trying to sell your shares for .0002? I’d rather get nothing or make a profit on this one holding for 3+ years

How many Lannett products does Elite manufacture? Lannett is a big real global company while Elite makes generic Adderall. Is Elite a poisonous thorn that doesn’t just sting, but kills?

$5 million

Elite manufactures amphetamine. Sorry you have no faith in the stock market, but Elite will be just fine as long as people continue eating drugs. They have at least 3,000 years of history on their side.

Well then I hope you know you just wasted a bunch of time.

That’s cool but if this goes back to .04 I know you’ll be buying too. Good luck.

Not in one month but I’ve bought plenty of .04, .06 and sold .08 and .12 over the years. Never expected to get rich but the occasional swings have been nice extra money.

This month alone it’s moved 10% up and down 7 times!!!

Bru it’s been .04 to .12 multiple times over the past 3 years since I’ve been watching. There has been money to be made the whole time. It’s not a problem with the company, it’s a problem with the investors

Why do so many people have so many shares? It speaks volumes more than anything you have to say on this board. You were wrong about getting rich just like your wrong about the SEC having ANY sort of benefit to the common shareholder. The SEC benefits any short position because they will never have to cover.

Best case scenario stock gets cancelled so other people can’t buy millions of shares thinking it’s a sure thing

Buyers remorse does not make a crooked company!

I think institutional investors might come to play too. I’m pretty sure it was over 90% last year and now 69% according to schwab. If that number grows I’ll have 0 worries here.

Too many saying incompetent management but there’s a case to be made for incompetent investors.

Anywhere from $1.00 to $3.14 per pill of Isradipine paid by Ohio Caid

It sure as heck isn’t .04

Can’t wait til finals roll around

Amerisource Bergen supplies Elite Adderall to any of their contracted pharmacies which includes Walgreens

SEC won’t get involved until it’s a billion dollar problem, then they will fine 25 million because they don’t go after healthcare like that.

Ok. But for how long. Sandlot long?? FOR-EV-ER? Highly doubt that

He calls it a $10 billion market so maybe IQVIVA is wrong and that guy is right.

Elite 2.0! I’d call Vyvanse abuse deterrent but that wouldn’t bode well for the company you mentioned.

It’s $830k on operating income and $943k R&D I really don’t care but point to the doc on this one

Y’all are hell bent on digging through posts to find out which incoherent thing is being referenced now.

You’re telling me... you can see it all over this board.

The almost billion shares. The series J that would probably double it. The financing keeps it down too. And the ice cold generics industry has been slashing profits even on increased revenues. They need to corner the market on a single source generic and drive the price through the roof (however congress has already seen this once and was about ready to castrate the conpanies doing it last time)

Thank you!